TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sequent Scientific Limited ( (IN:SEQUENT) ) has shared an update.
Sequent Scientific Limited has announced a merger scheme involving several companies, including Symed Labs Limited and Viyash Life Sciences Private Limited. The National Company Law Tribunal (NCLT) has sanctioned this scheme, and a share exchange ratio has been established, where Viyash will issue 47 equity shares for every 1 equity share of Geninn Life Sciences Private Limited. This merger is expected to consolidate operations and enhance market positioning for the involved entities.
More about Sequent Scientific Limited
Sequent Scientific Limited operates in the life sciences industry, focusing on pharmaceuticals and related services. The company is involved in the development, manufacturing, and marketing of pharmaceutical products, catering to various market needs.
Average Trading Volume: 109,416
Technical Sentiment Signal: Buy
Current Market Cap: 60.34B INR
Learn more about SEQUENT stock on TipRanks’ Stock Analysis page.